Learn · 03
For roughly half of people, the first symptom of heart disease is the event itself.
This is the domain where conventional screening and actual risk stratification diverge most sharply — and where the gap is least visible to the person being screened, because nothing about a reassuring result feels incomplete.
What people actually describe
Usually nothing. That is the defining feature of this domain and the reason it sits here. What brings people to the question is rarely a symptom — it is a family history, a sibling’s event, a lipid panel that has drifted, or simply having reached an age where the question stops being abstract.
Many arrive having already been screened and reassured. That reassurance is what we most often end up examining.
What the standard tools were built to do
Population risk calculators estimate the likelihood of an event over ten years from age, sex, blood pressure, lipids, and a few other inputs. They are useful instruments, honestly constructed, and they are population tools — they describe a cohort, not the person in the room. A substantial share of people who go on to have a major cardiac event were classified as low risk beforehand.
A coronary calcium score has a narrower limitation, and a more consequential one. It measures calcified plaque — disease that has already stabilized. Soft, lipid-rich, non-calcified plaque is invisible to it by definition. That is not a flaw in the test; it is what the test measures. But it is also the plaque most associated with rupture, and it is disproportionately what you find in people under sixty.
A calcium score of zero in a fifty-year-old therefore answers a question that was not the one being asked.
A published case report from this practice describes exactly this: a member with a calcium score of zero, classified low risk, whose imaging showed substantial non-calcified plaque in the proximal LAD.
What we look at instead
Plaque itself
Advanced coronary imaging that characterizes plaque volume and composition — not only whether calcium is present, but what is there and what kind.
Advanced lipids
Particle number and lipoprotein(a) rather than a standard panel alone. Lp(a) is largely genetic, meaningfully predictive, and almost never ordered.
Inflammation
Markers of the vascular inflammatory environment, which modifies how existing disease behaves.
Metabolic drivers
Insulin resistance and visceral fat — upstream contributors that shape arterial disease years before it appears.
Vascular environment
The condition of the vasculature as a system, reported in a member’s Vascular Health analysis alongside the Healthspan Index.
Cardiorespiratory fitness
Measured directly. Among the strongest single predictors of cardiovascular mortality available.
Why finding it early is the whole point
Non-calcified plaque is not a life sentence. It responds to aggressive lipid management, metabolic treatment, and targeted therapy — which is precisely why the timing of the diagnosis determines the outcome. Found early, this is a managed condition. Found at the event, it is an emergency, and frequently the first and last time it is discussed.
None of these tests is exclusive to us. Coronary imaging, advanced lipid panels, and Lp(a) are established medicine, available anywhere with the equipment and the expertise to interpret them. What differs is whether they get ordered when a conventional workup has already said there is nothing further to find.
Request a conversation.
If you have been reassured by a screening result and want to know what it did not cover, we should talk.
Request a conversation